Clinical Trial Update: Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 1/2 study assessing the pharmacokinetics, biodistribution, radiation dose, and safety of the radiopharmaceutical 68Ga-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-NYM032

Snippet

Sponsor: Norroy Bioscience Co., LTD | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED